US: FDA clears Novavax COVID-19 shots for adults

1 views | Jul 14, 2022, 01:59:25 PM | AP
  • Share
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that's already available in Europe and multiple other countries. Nearly a quarter of American adults still haven't gotten their primary vaccinations even this late in the pandemic, and experts expect at least some of them to roll up their sleeves for a more conventional option — a protein-based vaccine. The Maryland company also hopes its shots can become a top booster choice in the U.S. and beyond. Tens of millions of Americans still need boosters that experts call critical for the best possible protection as the coronavirus continues to mutate. For now, the FDA authorized Novavax's initial two-dose series for people 18 and older. Before shots begin, the Centers for Disease Control and Prevention must recommend how they should be used, a decision expected next week.